Fequesetide
Fequesetide, a peptide segment, is the active site within the protein thymosin β4 responsible for actin binding, cell migration and wound healing[1].
Product Specifications
CAS Number
[476014-70-7]
UNSPSC
12352209
Target
Arp2/3 Complex
Type
Peptides
Related Pathways
Cytoskeleton
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/lkktetq.html
Purity
99.36
Solubility
H2O : ≥ 100 mg/mL
Smiles
O=C(N)CC[C@@H](C(O)=O)NC([C@H]([C@H](O)C)NC([C@H](CCC(O)=O)NC([C@H]([C@H](O)C)NC([C@H](CCCCN)NC([C@H](CCCCN)NC([C@H](CC(C)C)N)=O)=O)=O)=O)=O)=O
Molecular Formula
C36H66N10O13
Molecular Weight
846.97
References & Citations
[1]Emmie N M Ho, et al. Doping control analysis of TB-500, a synthetic version of an active region of thymosin β₄, in equine urine and plasma by liquid chromatography-mass spectrometry. J Chromatogr A. 2012 Nov 23;1265:57-69.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6497568-01 0.2 mL
ARHGDIA, CT (Rho GDP-dissociation Inhibitor 1, Rho GDI 1, Rho-GDI alpha, GDIA1) (HRP)
Ask
View Details 
MBS6497568-02 5x 0.2 mL
ARHGDIA, CT (Rho GDP-dissociation Inhibitor 1, Rho GDI 1, Rho-GDI alpha, GDIA1) (HRP)
Ask
View Details 
GTR15340895 1 Vial
Lentiviral human CHST4 shRNA (UAS) - Lentiviral human CHST4 shRNA (UAS, GFP) (25)
Ask
View Details